Your Kidneys and Your Outlook
At a Glance
In AA amyloidosis, kidney outlook is shaped by the extent of amyloid deposits, eGFR and proteinuria trends, and control of the underlying inflammation. Lower SAA levels can help stabilize kidney function, while heart or gut involvement also affects overall prognosis.
For many people with AA amyloidosis, the kidneys are the main area of concern. Because the kidneys serve as the body’s filtration system, they are particularly vulnerable to the buildup of amyloid fibrils [1]. Understanding how your kidneys are affected and how doctors measure that damage can help you play an active role in your long-term care.
How Amyloid Damages the Kidney
The kidney is made up of millions of tiny filtering units called nephrons. Amyloid fibrils typically settle in three main areas of these units:
- The Glomeruli: These are the actual “filters” of the kidney. When amyloid builds up here, the filters become leaky [2]. This allows protein that should stay in your blood to spill into your urine, a condition called proteinuria [3].
- The Vessels: Amyloid can also deposit in the walls of the blood vessels that supply the kidney. This can restrict blood flow and lead to further organ damage [2].
- The Tubulointerstitial Area: This is the surrounding tissue and “plumbing” of the kidney. Damage here is often a sign of chronic, long-term scarring [4].
Predicting the Future: Clinical Markers
To understand your prognosis—the likely course of your disease—doctors look at clinical trends over time. Two primary numbers help guide this assessment:
1. Estimated Glomerular Filtration Rate (eGFR)
The eGFR is a measure of how well your kidneys are cleaning your blood.
- Population Associations: Research in large cohorts has shown that lower eGFR levels at the time of diagnosis are associated with a higher risk of progressing to end-stage kidney disease [5][6]. For example, some studies note that patients starting with an eGFR below 60 mL/min face a steeper clinical challenge than those with a higher eGFR [7].
- Individual Context: It is important to remember that these thresholds are not fixed rules for individuals. Your specific risk changes continuously based on your age, how well your inflammation is controlled, your blood pressure, and how much protein you are losing.
2. Proteinuria
The amount of protein in your urine is a direct reflection of how much damage the amyloid is doing to the kidney’s filters.
- Nephrotic Range: If you are losing massive amounts of protein (more than 3.5 grams in a day), it can lead to complications like severe swelling and low blood albumin [8].
- Improving the Outlook: A reduction in proteinuria after starting treatment is a very positive sign, though it must be evaluated alongside your eGFR [9].
Pathological Scoring (RAPS)
In recent years, some specialists have used the Renal Amyloid Prognostic Score (RAPS) as an optional tool to help gauge prognosis based on what is seen under the microscope [4].
The RAPS system looks at several factors from your biopsy:
- Glomerular Deposit Extent: How many of your filters contain amyloid?
- Vascular Deposits: The presence of amyloid in the blood vessel walls.
- Tubulointerstitial Injury: The amount of scarring or inflammation in the background tissue [4].
These factors are used to assign a RAPS Grade. While this score can be helpful, it is a newer, center-dependent tool, meaning not every pathology lab uses it. Your full clinical picture—your eGFR trend, SAA levels, and overall health—remains more important than any single score.
Long-Term Outlook
It is important to remember that AA amyloidosis is not a static condition. Your prognosis is heavily influenced by how quickly the “fire” of your underlying inflammation is put out.
- Stabilization: If SAA levels are brought down to a safe range, kidney function can sometimes remain stable for years [1][10].
- Extra-Renal Factors: While the kidneys are vital, your overall prognosis also depends on whether amyloid has affected other organs like the heart or gut [5]. A comprehensive view of your health helps ensure every part of your body is protected. [11]
Common questions in this guide
How does AA amyloidosis affect the kidneys?
What does eGFR tell me about AA amyloidosis?
What does proteinuria mean in AA amyloidosis?
What is the RAPS score for kidney amyloidosis?
Can kidney function stay stable with AA amyloidosis?
How often should kidney function and urine protein be checked?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current eGFR, and what does the trend over the last few months tell us about my kidney function?
- 2.Based on my kidney biopsy, was there extensive glomerular involvement or scarring in the tubulointerstitial area?
- 3.Does your pathology lab calculate a RAPS (Renal Amyloid Prognostic Score), and if so, how does that fit into my overall picture?
- 4.How frequently should we monitor my urine protein levels to see if our treatments are working?
- 5.What can I do from a lifestyle or supportive care perspective to help preserve my current kidney function?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
French practical guidelines for the diagnosis and management of AA amyloidosis.
Georgin-Lavialle S, Savey L, Buob D, et al.
La Revue de medecine interne 2023; (44(2)):62-71 doi:10.1016/j.revmed.2022.12.004.
PMID: 36759076 - 2
Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis.
Ozdemir A, Yılmaz M, Ozagari AA, Kocak SY
International urology and nephrology 2022; (54(10)):2591-2597 doi:10.1007/s11255-022-03163-y.
PMID: 35275358 - 3
Renal AA amyloidosis associated with inflammatory bowel disease.
Zran N, Chargui S, Azzabi A, et al.
BMC nephrology 2026; (27(1)).
PMID: 42143272 - 4
A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis.
Celtik A, Sen S, Keklik F, et al.
International urology and nephrology 2020; (52(7)):1297-1304 doi:10.1007/s11255-020-02505-y.
PMID: 32529382 - 5
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey.
Bektas M, Koca N, Oguz E, et al.
Rheumatology (Oxford, England) 2024; (63(2)):319-328 doi:10.1093/rheumatology/kead465.
PMID: 37738242 - 6
Renal outcomes and survival in amyloidosis associated with familial Mediterranean fever: A longitudinal study.
Ozeri DJ, Bar D, Somech Safran B, et al.
Seminars in arthritis and rheumatism 2025; (71()):152642 doi:10.1016/j.semarthrit.2025.152642.
PMID: 39908750 - 7
Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M, Komatsuda A, Ohtani H, et al.
Clinical and experimental nephrology 2017; (21(2)):212-227 doi:10.1007/s10157-016-1271-y.
PMID: 27116248 - 8
[Pathological and clinical correlations in renal AA amyloidosis: A Moroccan series of 30 cases].
Bziz A, Rouas L, Lamalmi N, et al.
Nephrologie & therapeutique 2015; (11(7)):543-50.
PMID: 26608566 - 9
Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis.
Almenara Tejederas M, Alonso García F, Aguilera Morales WA, et al.
Nefrologia 2021; doi:10.1016/j.nefro.2021.01.006.
PMID: 34140177 - 10
Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
Lane T, Gillmore JD, Wechalekar AD, et al.
Clinical and experimental rheumatology 2015; (33(6 Suppl 94)):S46-53.
PMID: 26120866 - 11
[Renal amyloidoses in nephrology].
Koumou GCG, Sinomono DTE, Merzouk S, et al.
The Pan African medical journal 2019; (34()):79 doi:10.11604/pamj.2019.34.79.8722.
PMID: 31934222
This page explains kidney involvement and prognosis in AA amyloidosis for informational purposes only and does not constitute medical advice. Your nephrologist and treating team can interpret your eGFR, urine protein, biopsy, and SAA results.
Get notified when new evidence is published on AA amyloidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.